| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Dec 17, 2025 | Fulcrum Therapeutics, Inc. | Chief Legal Officer | Sell | 13.8 | -3,452 | -25.19% | ✓ | $44.6K |
| Jun 28, 2021 | Jun 29, 2021 | Fulcrum Therapeutics, Inc. | SVP, General Counsel | Buy | 90.0 | +1,088 | 100.00% | ✗ | $9.8K |